Brief: Cullinan Oncology Q4 Adjusted Net Income USD -25.6 Million

Cullinan Therapeutics

14/03/2024 11:00

Mar 14 (Reuters) - Cullinan Oncology Q4 net income USD -25.563 million.
* Q4 operating expenses USD 45.485 million
* Q4 operating income USD -45.485 million
* Q4 pretax profit USD -39.685 million
* Q4 cash & investments USD 468.3 million